High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$3.3M
$3,277,635
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
COCP
P
Cocrystal Pharma, Inc.
FROST PHILLIP MD ET AL
• Director
Discretionary Buy
2026-02-24
$19,952
|
||||||
| COCP |
Cocrystal Pharma, Inc.
|
Director
Discretionary Buy
|
2026-02-24 | $19,952 | P | Form 4 |
|
COCP
P
Cocrystal Pharma, Inc.
FROST PHILLIP MD ET AL
• Director
Discretionary Buy
2026-02-06
$47,280
|
||||||
| COCP |
Cocrystal Pharma, Inc.
|
Director
Discretionary Buy
|
2026-02-06 | $47,280 | P | Form 4 |
|
COCP
P
Cocrystal Pharma, Inc.
FROST PHILLIP MD ET AL
• Director
Discretionary Buy
2025-11-25
$18,812
|
||||||
| COCP |
Cocrystal Pharma, Inc.
|
Director
Discretionary Buy
|
2025-11-25 | $18,812 | P | Form 4 |
| OPK |
OPKO HEALTH, INC.
|
CEO
Discretionary Buy
|
2025-11-21 | $768,807x5 | P | Form 4 |
| OPK |
OPKO HEALTH, INC.
|
CEO
Discretionary Buy
|
2025-11-20 | $771,328x7 | P | Form 4 |
| OPK |
OPKO HEALTH, INC.
|
CEO
Discretionary Buy
|
2025-11-19 | $759,115x9 | P | Form 4 |
| OPK |
OPKO HEALTH, INC.
|
CEO
Discretionary Buy
|
2025-11-18 | $678,906x11 | P | Form 4 |
| OPK |
OPKO HEALTH, INC.
|
CEO
Discretionary Buy
|
2025-10-31 | $213,435 | P | Form 4 |